Trial Identifier: | D5180R00027 |
Sponsor: | AstraZeneca |
Start Date: | April 2024 |
Primary Completion Date: | September 2024 |
Study Completion Date: | September 2024 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
United Kingdom | Birmingham, United Kingdom |
United Kingdom | Liverpool, United Kingdom |
United Kingdom | London, United Kingdom |
United Kingdom | Plymouth, United Kingdom |
United Kingdom | Southampton, United Kingdom |